ReviewPharmaceutics2022

Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs.

Damiano Bartolucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.